Reduction of GAPDH in lenses of Parkinson's disease patients: A possible new biomarker

Mov Disord. 2017 Mar;32(3):459-462. doi: 10.1002/mds.26863. Epub 2016 Nov 10.

Abstract

Background: We previously showed that the protein pattern of lenses removed in cataract surgery differs between patients with Parkinson's disease and age-matched controls. In this study, we identified the protein reduced in abundance in the 34- to 37-kDa gel band.

Methods: During cataract surgery (phacoemulsification), we collected the rinsing fluid and lens particles from the eyes of PD patients and controls. Residual lens fragments in the supernatant of 3 PD patients and aged-matched controls were studied for protein profiles using liquid chromatography-mass spectrometry and Western blots.

Results: We identified glyceraldehyde-3-phosphate dehydrogenase by mass spectrometry as the protein reduced in abundance and verified this finding in Western blots.

Conclusions: Glyceraldehyde-3-phosphate dehydrogenase has been implicated in PD development. The reduction of glyceraldehyde-3-phosphate dehydrogenase in the lenses of PD patients may be a new biomarker for PD and might also indicate an important role for this protein in PD development. © 2016 International Parkinson and Movement Disorder Society.

Keywords: GAPDH; Parkinson's disease; cataract.

MeSH terms

  • Aged
  • Biomarkers / metabolism
  • Cataract Extraction
  • Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) / metabolism*
  • Humans
  • Lens, Crystalline / metabolism*
  • Parkinson Disease / diagnosis
  • Parkinson Disease / metabolism*

Substances

  • Biomarkers
  • GAPDHS protein, human
  • Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)